造影剂肾病危险因素新认识

被引：10

作者：

张翩

倪兆慧

机构：

[1] 上海交通大学医学附属仁济医院肾脏科

来源：

中国血液净化 | 2009年 / 8卷 / 05期

关键词：

造影剂; 造影剂肾病; 危险因素;

D O I：

暂无

中图分类号：

R692 [肾疾病];

学科分类号：

100221 [泌尿外科学];

摘要：

造影剂在临床的广泛应用使造影剂肾病(CIN)成为院内获得性急性肾损伤(AKI)的常见病因。正确识别CIN危险因素有利于预防CIN发生,不仅可降低住院费用而且可改善患者预后。CIN的危险因素包括已存在肾脏病、糖尿病、高龄、使用高渗离子型造影剂等,本文仅就近年文献对CIN危险因素做一综述并介绍几种对危险因素进行评估的方法。

引用

页码：270 / 274

页数：5

共 14 条

[1]

Serious renal dysfunction after percutaneous coronary interventions can be predicted [J].

Brown, Jeremiah R. ;

DeVries, James T. ;

Piper, Winthrop D. ;

Robb, John F. ;

Hearne, Michael J. ;

Lee, Peter M. Ver ;

Kellet, Mirle A. ;

Watkins, Mathew W. ;

Ryan, Thomas J. ;

Silver, M. Theodore ;

Ross, Cathy S. ;

MacKenzie, Todd A. ;

O'Connor, Gerald T. ;

Malenka, David J. .

AMERICAN HEART JOURNAL, 2008, 155 (02) :260-266

[2]

Renal effects of contrast media in diabetic patients undergoing diagnostic or interventional coronary angiography [J].

Hardiek, Kathy J. ;

Katholi, Richard E. ;

Robbs, Randall S. ;

Katholi, Charles E. .

JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2008, 22 (03) :171-177

[3]

Incidence, predictors, and outcomes of post-percutaneous coronary intervention nephropathy in patients with diabetes mellitus and normal baseline serum creatinine levels [J].

Roy, Probal ;

Raya, Vikram ;

Okabe, Teruo ;

Slottow, Tina L. Pinto ;

Steinberg, Daniel H. ;

Smith, Kimberly ;

Xue, Zhenyi ;

Satler, Lowell F. ;

Kent, Kenneth M. ;

Suddath, William O. ;

Pichard, Augusto D. ;

Lindsay, Joseph ;

Waksman, Ron .

AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (11) :1544-1549

[4]

Urinary Excretion of Liver-Type Fatty Acid–Binding Protein in Contrast Medium–Induced Nephropathy.[J].Tsukasa Nakamura;Takeshi Sugaya;Koichi Node;Yoshihiko Ueda;Hikaru Koide.American Journal of Kidney Diseases.2006, 3

[5]

Risk factors and therapy strategies for contrast-induced nephropathy [J].